Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Management
Designation
No Data
Revenue and Profits:
Net Sales:
50 Million
(Quarterly Results - Mar 2026)
Net Profit:
-58 Million
Pharmaceuticals & Biotechnology
ILS 975 Million ()
NA (Loss Making)
NA
0.00%
1.40
-34.08%
2.46






